Search research articles

ABOUT JoVE

Overview Leadership Blog JoVE Help Center

AUTHORS

Publishing Process Editorial Board Scope & Policies Peer Review FAQ Submit

LIBRARIANS

Testimonials Subscriptions Access Resources Library Advisory Board FAQ

RESEARCH

JoVE Journal Methods Collections JoVE Encyclopedia of Experiments Archive

EDUCATION

JoVE Core JoVE Business JoVE Science Education JoVE Lab Manual Faculty Resource Center Faculty Site

Terms & Conditions of Use

Related Concept Videos

Positron Emission Tomography

Positron Emission Tomography

Positron emission tomography (PET) is a medical imaging technique involving radiopharmaceuticals — substances that emit short-lived radiation. Although the first PET scanner was introduced in 1961, it took 15 more years before radiopharmaceuticals were combined with the technique and revolutionized its potential.
One of the main requirements of a PET scan is a positron-emitting radioisotope, which is produced in a cyclotron and then attached to a substance used by the part of the body being...

Labeling DNA Probes

Labeling DNA Probes

DNA probes are fragments of DNA labeled with a reporter tag to enable their detection or purification. The resulting labeled DNA probes can then hybridize to target nucleic acid sequences through complementary base-pairing, and may be used to recover or identify these regions.
Radioisotopes, fluorophores, or small molecule binding partners like biotin or digoxigenin, are the most widely used reporter tags for labeling DNA probes. These labels can be attached to the probe DNA molecule via...

Imaging Studies II: Positron Emission Tomography and Scintigraphy

Imaging Studies II: Positron Emission Tomography and Scintigraphy

Positron Emission Tomography (PET) is a medical imaging technique that provides crucial insights into the body's physiological functions at a molecular level. It is an indispensable resource for diagnosing, staging, and monitoring various illnesses, notably cancer, neurological disorders, and cardiovascular conditions.
Fundamental Principles of PET

Tagging and Fusion Proteins

Tagging and Fusion Proteins

Proteins are involved in several cellular processes and biochemical reactions. Analyzing a specific protein of interest requires it to be isolated from the other proteins in the cell. This is achieved by overexpressing the specific gene in a suitable host to produce large quantities of the target protein. A tag or label is recombined with the gene to produce a fusion protein containing the target protein and the tag. The tags on these fusion proteins can then be used for easy detection and...

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by

Same author

Tremelimumab and durvalumab as neoadjuvant or non-operative management strategy of patients with microsatellite instability-high resectable gastric or gastroesophageal junction adenocarcinoma: the INFINITY study by GONO.

Annals of oncology : official journal of the European Society for Medical Oncology·2024

Same author

Identification of paramagnetic centers in irradiated Sn-doped silicon dioxide by first-principles.

Journal of physics. Condensed matter : an Institute of Physics journal·2024

Same author

Probing densified silica glass structure by molecular oxygen and E' center formation under electron irradiation.

Scientific reports·2023

Same author

Cabozantinib Plus Durvalumab in Patients With Advanced Urothelial Carcinoma After Platinum Chemotherapy: Safety and Preliminary Activity of the Open-Label, Single-Arm, Phase 2 ARCADIA Trial.

Clinical genitourinary cancer·2021

Same author

Pembrolizumab and nab-paclitaxel as salvage therapy for platinum-treated, locally advanced or metastatic urothelial carcinoma: interim results of the open-label, single-arm, phase II PEANUT study.

Annals of oncology : official journal of the European Society for Medical Oncology·2020

Same author

Anti-PSMA <sup>124</sup>I-scFvD2B as a new immuno-PET tool for prostate cancer: preclinical proof of principle.

Journal of experimental & clinical cancer research : CR·2019

Search research articles

Related Experiment Video

Updated: May 22, 2026

Enhancing Efficiency and Radiolabeling Yields of Carbon-11 Radioligands for Clinical Research Using the Loop Method

Enhancing Efficiency and Radiolabeling Yields of Carbon-11 Radioligands for Clinical Research Using the Loop Method

Published on: December 20, 2024

PET with radiolabeled aminoacid.

F Crippa¹, A Alessi, G L Serafini

¹National Cancer Institute, Milan, Italy. flavio.crippa@istitutotumori.mi.it

The Quarterly Journal of Nuclear Medicine and Molecular Imaging : Official Publication of the Italian Association of Nuclear Medicine (AIMN) [And] the International Association of Radiopharmacology (IAR), [And] Section of the Society Of

|May 24, 2012

Summary

Positron emission tomography (PET) amino acid imaging shows promise for brain tumor evaluation, offering advantages over FDG-PET. Newer tracers like FET enable wider accessibility for advanced neuro-oncology diagnostics.

More Related Videos

PET/CT With [68Ga]-NOTA-FAP-2286 for Imaging of Tendon Injuries in Rat Achilles Tendon Injury Models

PET/CT With [⁶⁸Ga]-NOTA-FAP-2286 for Imaging of Tendon Injuries in Rat Achilles Tendon Injury Models

Published on: June 6, 2025

Radiosynthesis, Quality Control, and Small Animal Positron Emission Tomography Imaging of 68Ga-Labelled Nano Molecules

Radiosynthesis, Quality Control, and Small Animal Positron Emission Tomography Imaging of ⁶⁸Ga-Labelled Nano Molecules

Published on: October 4, 2024

Related Experiment Videos

Last Updated: May 22, 2026

Enhancing Efficiency and Radiolabeling Yields of Carbon-11 Radioligands for Clinical Research Using the Loop Method

Enhancing Efficiency and Radiolabeling Yields of Carbon-11 Radioligands for Clinical Research Using the Loop Method

Published on: December 20, 2024

PET/CT With [68Ga]-NOTA-FAP-2286 for Imaging of Tendon Injuries in Rat Achilles Tendon Injury Models

PET/CT With [⁶⁸Ga]-NOTA-FAP-2286 for Imaging of Tendon Injuries in Rat Achilles Tendon Injury Models

Published on: June 6, 2025

Radiosynthesis, Quality Control, and Small Animal Positron Emission Tomography Imaging of 68Ga-Labelled Nano Molecules

Radiosynthesis, Quality Control, and Small Animal Positron Emission Tomography Imaging of ⁶⁸Ga-Labelled Nano Molecules

Published on: October 4, 2024

Area of Science:

Neuroimaging
Oncology
Nuclear Medicine

Background:

Fluorodeoxyglucose-PET (FDG-PET) has limitations in neuro-oncology due to unfavorable uptake characteristics in normal brain tissue.
Positron emission tomography (PET) applications in neuro-oncology have been advanced by the development of radiolabeled amino acid tracers.
Amino acid PET offers superior diagnostic potential for brain tumors, including low-grade gliomas, due to low normal brain uptake and high tumor uptake.

Purpose of the Study:

To review the diagnostic utility of L-[methyl-11C]Methionine (MET) in brain tumor evaluation.
To highlight the advantages of 18F-labeled amino acid tracers, such as O-(2-18F-fluoeoethyl1)-L-tyrosine (FET), over MET.
To discuss the future role of amino acid PET in neuro-oncology, considering advancements in PET tracers and integrated imaging systems.

Main Methods:

Review of studies utilizing L-[methyl-11C]Methionine (MET) for brain tumor imaging.
Comparison of MET with newer 18F-labeled amino acid tracers, particularly FET.
Discussion of emerging PET tracers for hypoxia (FMISO, 18F-FAZA) and proliferation (FLT) imaging.

Main Results:

L-[methyl-11C]Methionine (MET) is an effective amino acid PET tracer for brain tumors but requires an on-site cyclotron due to its short half-life.
O-(2-18F-fluoeoethyl1)-L-tyrosine (FET) offers similar diagnostic performance to MET but allows for wider distribution due to its longer half-life.
Advancements in PET tracers and integrated PET-MRI systems suggest a growing role for metabolic imaging in brain tumor management.

Conclusions:

Amino acid PET, particularly with tracers like MET and FET, is a valuable tool for brain tumor evaluation.
The development of longer-lived 18F-labeled amino acid tracers facilitates broader clinical application of amino acid PET.
Metabolic imaging with PET is poised to become a cornerstone in the management of brain tumors, similar to its role in extra-cranial oncology.